vs
Side-by-side financial comparison of ASTROTECH Corp (ASTC) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $148.0K, roughly 419.9× ASTROTECH Corp). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -2653.4%, a 2582.4% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -43.3%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-4.0M). Over the past eight quarters, ASTROTECH Corp's revenue compounded faster (72.0% CAGR vs 17.7%).
Astrotech Corporation, formerly Spacehab Inc., is a technology incubator headquartered in Austin, Texas. Astrotech uses technology sourced internally and from research institutions, government laboratories, and universities to fund, manage and sell start-up companies. Astrotech Corporation's subsidiaries provide commercial products and services to NASA, the U.S. Department of Defense, national space agencies, and global commercial customers.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
ASTC vs CTKB — Head-to-Head
Income Statement — Q2 2026 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $148.0K | $62.1M |
| Net Profit | $-3.9M | $-44.1M |
| Gross Margin | 5.4% | 52.9% |
| Operating Margin | -2635.8% | -9.0% |
| Net Margin | -2653.4% | -70.9% |
| Revenue YoY | -43.3% | 8.1% |
| Net Profit YoY | 2.0% | -557.1% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.0K | $62.1M | ||
| Q3 25 | $297.0K | $52.3M | ||
| Q2 25 | $220.0K | $45.6M | ||
| Q1 25 | $534.0K | $41.5M | ||
| Q4 24 | $261.0K | $57.5M | ||
| Q3 24 | $34.0K | $51.5M | ||
| Q2 24 | $74.0K | $46.6M | ||
| Q1 24 | $50.0K | $44.9M |
| Q4 25 | $-3.9M | $-44.1M | ||
| Q3 25 | $-3.5M | $-5.5M | ||
| Q2 25 | $-2.9M | $-5.6M | ||
| Q1 25 | $-3.6M | $-11.4M | ||
| Q4 24 | $-4.0M | $9.6M | ||
| Q3 24 | $-3.3M | $941.0K | ||
| Q2 24 | $-3.0M | $-10.4M | ||
| Q1 24 | $-3.2M | $-6.2M |
| Q4 25 | 5.4% | 52.9% | ||
| Q3 25 | 63.3% | 52.7% | ||
| Q2 25 | 33.6% | 52.3% | ||
| Q1 25 | 44.4% | 48.6% | ||
| Q4 24 | 59.4% | 58.5% | ||
| Q3 24 | 26.5% | 56.3% | ||
| Q2 24 | 37.8% | 54.6% | ||
| Q1 24 | 16.0% | 51.3% |
| Q4 25 | -2635.8% | -9.0% | ||
| Q3 25 | -1190.6% | -17.6% | ||
| Q2 25 | -1326.4% | -23.3% | ||
| Q1 25 | -724.2% | -36.1% | ||
| Q4 24 | -1655.6% | 5.2% | ||
| Q3 24 | -10670.6% | -8.2% | ||
| Q2 24 | -4518.9% | -18.3% | ||
| Q1 24 | -7066.0% | -23.9% |
| Q4 25 | -2653.4% | -70.9% | ||
| Q3 25 | -1166.7% | -10.5% | ||
| Q2 25 | -1331.8% | -12.2% | ||
| Q1 25 | -680.3% | -27.5% | ||
| Q4 24 | -1536.0% | 16.8% | ||
| Q3 24 | -9641.2% | 1.8% | ||
| Q2 24 | -3998.6% | -22.4% | ||
| Q1 24 | -6308.0% | -13.8% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.0M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.5M | $341.7M |
| Total Assets | $19.7M | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.0M | $90.9M | ||
| Q3 25 | $11.3M | $93.3M | ||
| Q2 25 | $15.1M | $75.5M | ||
| Q1 25 | $18.1M | $95.3M | ||
| Q4 24 | $21.5M | $98.7M | ||
| Q3 24 | $21.8M | $162.3M | ||
| Q2 24 | $42.9M | $177.9M | ||
| Q1 24 | $52.4M | $168.8M |
| Q4 25 | $15.5M | $341.7M | ||
| Q3 25 | $19.1M | $378.6M | ||
| Q2 25 | $22.1M | $377.6M | ||
| Q1 25 | $24.8M | $379.6M | ||
| Q4 24 | $28.1M | $395.7M | ||
| Q3 24 | $32.1M | $385.5M | ||
| Q2 24 | $34.8M | $389.1M | ||
| Q1 24 | $37.6M | $392.6M |
| Q4 25 | $19.7M | $461.5M | ||
| Q3 25 | $23.2M | $494.9M | ||
| Q2 25 | $27.0M | $493.3M | ||
| Q1 25 | $27.5M | $482.6M | ||
| Q4 24 | $31.0M | $499.5M | ||
| Q3 24 | $34.4M | $491.2M | ||
| Q2 24 | $37.6M | $483.7M | ||
| Q1 24 | $40.2M | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | $-771.0K |
| Free Cash FlowOCF − Capex | $-4.0M | $-1.8M |
| FCF MarginFCF / Revenue | -2671.6% | -2.9% |
| Capex IntensityCapex / Revenue | 277.7% | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-14.9M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.5M | $-771.0K | ||
| Q3 25 | $-3.9M | $-3.9M | ||
| Q2 25 | $-2.4M | $108.0K | ||
| Q1 25 | $-3.9M | $-125.0K | ||
| Q4 24 | $-3.0M | $2.0M | ||
| Q3 24 | $-3.7M | $13.2M | ||
| Q2 24 | $-2.5M | $6.2M | ||
| Q1 24 | $-2.3M | $4.0M |
| Q4 25 | $-4.0M | $-1.8M | ||
| Q3 25 | $-4.4M | $-4.6M | ||
| Q2 25 | $-2.7M | $-1.5M | ||
| Q1 25 | $-3.9M | $-974.0K | ||
| Q4 24 | $-3.4M | $1.1M | ||
| Q3 24 | $-3.9M | $12.2M | ||
| Q2 24 | $-2.8M | $5.2M | ||
| Q1 24 | $-2.5M | $3.4M |
| Q4 25 | -2671.6% | -2.9% | ||
| Q3 25 | -1476.1% | -8.7% | ||
| Q2 25 | -1231.4% | -3.2% | ||
| Q1 25 | -728.1% | -2.3% | ||
| Q4 24 | -1288.5% | 1.9% | ||
| Q3 24 | -11408.8% | 23.7% | ||
| Q2 24 | -3728.4% | 11.0% | ||
| Q1 24 | -5036.0% | 7.6% |
| Q4 25 | 277.7% | 1.6% | ||
| Q3 25 | 150.8% | 1.3% | ||
| Q2 25 | 158.2% | 3.5% | ||
| Q1 25 | 5.1% | 2.0% | ||
| Q4 24 | 122.2% | 1.6% | ||
| Q3 24 | 567.6% | 2.0% | ||
| Q2 24 | 305.4% | 2.3% | ||
| Q1 24 | 352.0% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTC
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
